Aram, Baby Girl .
HRN: 24-32-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2024
CEFTAZIDIME 1GM (VIAL)
02/11/2024
02/18/2024
IV
40mg
Q12h
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes